参考文献
[1]Prat J,Mbatani’N.Uterine sarcomas[J].Int J Gynaecol Obstet,2015,131(Suppl2):S105- S110.
[2]Oliva E,Carcangiu M L,Carinelli S G,et al.Mesenchymal tumours[A].In:Kurman R J,Carcangiu M L,Herrington C S,Young RH,editors.WHO Classification of Tumours of Female Reproductive Organs[M].4th ed.Lyon:IARC,2014:135-47.
[3]Tropé CG1,Abeler V M,Kristensen G B.Diagnosis and treatment of sarcoma of the uterus.A review.Acta Oncol,2012,51(6):694-705.
[4]Prat J.FIGO staging for uterine sarcomas[J].Int J Gynaecol Obstet,2009,104(3):177-178.[Erratum in:Int J Gynaecol Obstet,2009,106(3):277]
[5]Rauh-Hain J A,del Carmen M G.Endometrial stromal sarcoma:a systematic review[J].Obstet Gynecol,2013,122(3):676-683.
[6]Yoon A,Park J Y,Park J Y,et al.Prognostic factors and outcomes in endometrial stromal sarcoma with the 2009 FIGO staging system:a multicenter review of 114 cases[J].Gynecol Oncol,2014,132(1):70-75.
[7]Reich O,Regauer S.Estrogen replacement therapy and tamoxifen are contraindicated in patients with endometrial stromal sarcoma[J].Gynecol Oncol,2006,102(2):413-414.
[8]Bogani G,Cliby W A,Aletti G D.Impact of morcellation on survival outcomes of patients with unexpected uterine leiomyosarcoma:a systematic review and metaanalysis[J].Gynecol Oncol,2015,137(1):167-172.
[9]Reichardt P.The treatment of uterine sarcomas[J].Ann Oncol,2012,23(Suppl 10):x151-x157.(https://www.daowen.com)
[10]Reed N S,Mangioni C,Malmström H,et al.Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II:an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study(protocol 55874)[J].Eur J Cancer,2008,44(6):808-818.
[11]Amant F,Floquet A,Friedlander M,et al.Gynecologic Cancer InterGroup(GCIG)consensus review for endometrial stromal sarcoma[J].Int J Gynecol Cancer,2014,24(9 Suppl 3):S67-72.
[12]Hyman D M,Grisham R N,Hensley M L.Management of advanced uterine leiomyosarcoma[J].Curr Opin Oncol,2014,26(4):422-427.
[13]Pautier P,Nam E J,Provencher D M,et al.Gynecologic Cancer InterGroup(GCIG)consensus review for high-grade undiあerentiated sarcomas of the uterus[J].Int J Gynecol Cancer,2014,24(9 Suppl 3):S73-77.
[14]Hensley M L,Miller A,O’Malley D M,et al.Randomized phase III trial of gemcitabine plus docetaxel plus bevacizumab or placebo as first-line treatment for metastatic uterine leiomyosarcoma:an NRG Oncology/Gynecologic Oncology Group study[J].J Clin Oncol,2015,33(10):1180-1185.
[15]Klopp A,Smith B D,Alektiar K,et al.The role of postoperative radiation therapy for endometrial cancer:Executive summary of an American Society for Radiation Oncology evidence-based guideline[J].Pract Radiat Oncol,2014,4(3):137-144.
[16]郝敏，杨婧.子宫肉瘤的诊治进展和争议问题[J].实用肿瘤杂志，2016，31（6）：502-504.
[17]陆晓燕，徐坚．彩色多普勒超声在诊断子宫肌瘤肉瘤变中的应用［J］．实用临床医药杂志，2011，15（13）：121-122.